Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/31/24
Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial GuidancePRNewsWire • 07/31/24
Jazz Pharmaceuticals Shareholders Elect Laura Hamill to the Company's Board of Directors at Annual General MeetingPRNewsWire • 07/25/24
Jazz Pharmaceuticals Announces Successful Completion of Term Loan Repricing and Irrevocable Election of Settlement Method for the 2.000% Exchangeable Senior Notes due 2026PRNewsWire • 07/22/24
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 NamesInvestorPlace • 07/19/24
Jazz Pharmaceuticals to Report 2024 Second Quarter Financial Results on July 31, 2024PRNewsWire • 07/17/24
Is The Options Market Predicting A Spike In JAZZ Pharmaceuticals (JAZZ) Stock?Zacks Investment Research • 07/11/24
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug FailureInvestors Business Daily • 06/20/24
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential TremorPRNewsWire • 06/20/24
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024PRNewsWire • 06/01/24